Loading…
Response to Human Metapneumovirus Outbreak in China
Inspira Technologies, a developer of respiratory support systems, has initiated preparations for a potential increase in production of its INSPIRA ART100 device. This move comes in response to the recent outbreak of Human Metapneumovirus in China, which has heightened demand for advanced respiratory care solutions.
The company is currently assessing the necessary adjustments to its manufacturing processes and supply chain to accommodate the anticipated rise in demand for the INSPIRA ART100 device. No specific production targets or timelines have been disclosed at this stage.
As of the latest available data, Inspira Technologies has a free float of 27,122,800 shares.
This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.